Prostate Cancer Nuclear Medicine Diagnostics Market Report

Global and China Prostate Cancer Nuclear Medicine Diagnostics Industry Market Research Report (2017-2028)

  • POSTDATE：Oct 30, 2022
  • PAGES：201
  • REPORT CODE：GMM1329725
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Prostate Cancer Nuclear Medicine Diagnostics industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Telix Pharmaceuticals Ltd

    • Alliance Medical

    • NCM-USA LLC

    • Jubilant Pharma Limited

    • PETNET Solutions Inc

    • Novartis AG

    • Cardinal Health

    • Lantheus Medical Imagining, Inc

    • Cancer Genetics, Inc

    • Curium Pharma

    • Blue Earth Diagnostics

    • ImaginAb

    • American Pride

    • Theragnostics Ltd

    • Sun Nuclear Corporation

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Single Photon Emission Computed Tomography

    • Positron Emission Tomography

    Application:

    • Hospitals

    • Clinics

    • Others

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Prostate Cancer Nuclear Medicine Diagnostics Industry Overview

      • 1.1.1 Prostate Cancer Nuclear Medicine Diagnostics Market Scope and Market Segments

      • 1.1.2 Prostate Cancer Nuclear Medicine Diagnostics Industry Characteristics

      • 1.1.3 Global and China Prostate Cancer Nuclear Medicine Diagnostics Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Prostate Cancer Nuclear Medicine Diagnostics Production Value and Growth Rate (2017-2028)

    • 1.2 Global Prostate Cancer Nuclear Medicine Diagnostics Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Single Photon Emission Computed Tomography

      • 1.2.2 Positron Emission Tomography

    • 1.3 Global Prostate Cancer Nuclear Medicine Diagnostics Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Hospitals

      • 1.3.2 Clinics

      • 1.3.3 Others

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Prostate Cancer Nuclear Medicine Diagnostics Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Prostate Cancer Nuclear Medicine Diagnostics Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Prostate Cancer Nuclear Medicine Diagnostics Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Prostate Cancer Nuclear Medicine Diagnostics Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Prostate Cancer Nuclear Medicine Diagnostics Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Prostate Cancer Nuclear Medicine Diagnostics Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Prostate Cancer Nuclear Medicine Diagnostics Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Prostate Cancer Nuclear Medicine Diagnostics Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Prostate Cancer Nuclear Medicine Diagnostics Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Prostate Cancer Nuclear Medicine Diagnostics Industry Porter's Five Forces Model Analysis

      • 2.2.3 Prostate Cancer Nuclear Medicine Diagnostics Industry PEST Analysis

    • 2.3 Prostate Cancer Nuclear Medicine Diagnostics Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Prostate Cancer Nuclear Medicine Diagnostics Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Prostate Cancer Nuclear Medicine Diagnostics Industry

    Chapter 3 Global and China Prostate Cancer Nuclear Medicine Diagnostics Market, by Manufacturer

    • 3.1 Global and China Prostate Cancer Nuclear Medicine Diagnostics Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Prostate Cancer Nuclear Medicine Diagnostics Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Prostate Cancer Nuclear Medicine Diagnostics Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Prostate Cancer Nuclear Medicine Diagnostics Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Prostate Cancer Nuclear Medicine Diagnostics Market Top 3 Players

    Chapter 4 Global and China Prostate Cancer Nuclear Medicine Diagnostics Market, by Type (2017-2028)

    • 4.1 Prostate Cancer Nuclear Medicine Diagnostics Market Trend, by Type

    • 4.2 Global Prostate Cancer Nuclear Medicine Diagnostics Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Prostate Cancer Nuclear Medicine Diagnostics Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Prostate Cancer Nuclear Medicine Diagnostics Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Prostate Cancer Nuclear Medicine Diagnostics Price Trend, by Type (2017-2028)

    • 4.3 China Prostate Cancer Nuclear Medicine Diagnostics Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Prostate Cancer Nuclear Medicine Diagnostics Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Prostate Cancer Nuclear Medicine Diagnostics Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Prostate Cancer Nuclear Medicine Diagnostics Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Prostate Cancer Nuclear Medicine Diagnostics Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Prostate Cancer Nuclear Medicine Diagnostics Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Prostate Cancer Nuclear Medicine Diagnostics Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Prostate Cancer Nuclear Medicine Diagnostics Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Prostate Cancer Nuclear Medicine Diagnostics Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Prostate Cancer Nuclear Medicine Diagnostics Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Prostate Cancer Nuclear Medicine Diagnostics Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Prostate Cancer Nuclear Medicine Diagnostics Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Prostate Cancer Nuclear Medicine Diagnostics Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Prostate Cancer Nuclear Medicine Diagnostics Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Prostate Cancer Nuclear Medicine Diagnostics Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Prostate Cancer Nuclear Medicine Diagnostics Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Prostate Cancer Nuclear Medicine Diagnostics Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Prostate Cancer Nuclear Medicine Diagnostics Market Analysis

    • 7.1 North America Prostate Cancer Nuclear Medicine Diagnostics Market, by Type

    • 7.2 North America Prostate Cancer Nuclear Medicine Diagnostics Market, by Application

    • 7.3 North America Prostate Cancer Nuclear Medicine Diagnostics Market Analysis and Forecast, by Country

      • 7.3.1 United States Prostate Cancer Nuclear Medicine Diagnostics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Prostate Cancer Nuclear Medicine Diagnostics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Prostate Cancer Nuclear Medicine Diagnostics Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Prostate Cancer Nuclear Medicine Diagnostics Market Analysis

    • 8.1 Europe Prostate Cancer Nuclear Medicine Diagnostics Market, by Type

    • 8.2 Europe Prostate Cancer Nuclear Medicine Diagnostics Market, by Application

    • 8.3 Europe Prostate Cancer Nuclear Medicine Diagnostics Market Analysis and Forecast, by Country

      • 8.3.1 Germany Prostate Cancer Nuclear Medicine Diagnostics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Prostate Cancer Nuclear Medicine Diagnostics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Prostate Cancer Nuclear Medicine Diagnostics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Prostate Cancer Nuclear Medicine Diagnostics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Prostate Cancer Nuclear Medicine Diagnostics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Prostate Cancer Nuclear Medicine Diagnostics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Prostate Cancer Nuclear Medicine Diagnostics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Prostate Cancer Nuclear Medicine Diagnostics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Prostate Cancer Nuclear Medicine Diagnostics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Prostate Cancer Nuclear Medicine Diagnostics Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Prostate Cancer Nuclear Medicine Diagnostics Market Analysis

    • 9.1 APAC Prostate Cancer Nuclear Medicine Diagnostics Market, by Type

    • 9.2 APAC Prostate Cancer Nuclear Medicine Diagnostics Market, by Application

    • 9.3 APAC Prostate Cancer Nuclear Medicine Diagnostics Market Analysis and Forecast, by Country

      • 9.3.1 China Prostate Cancer Nuclear Medicine Diagnostics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Prostate Cancer Nuclear Medicine Diagnostics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Prostate Cancer Nuclear Medicine Diagnostics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Prostate Cancer Nuclear Medicine Diagnostics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Prostate Cancer Nuclear Medicine Diagnostics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Prostate Cancer Nuclear Medicine Diagnostics Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Prostate Cancer Nuclear Medicine Diagnostics Market Analysis

    • 10.1 Latin America, Middle East and Africa Prostate Cancer Nuclear Medicine Diagnostics Market, by Type

    • 10.2 Latin America, Middle East and Africa Prostate Cancer Nuclear Medicine Diagnostics Market, by Application

    • 10.3 Latin America, Middle East and Africa Prostate Cancer Nuclear Medicine Diagnostics Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Prostate Cancer Nuclear Medicine Diagnostics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Prostate Cancer Nuclear Medicine Diagnostics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Prostate Cancer Nuclear Medicine Diagnostics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Prostate Cancer Nuclear Medicine Diagnostics Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Prostate Cancer Nuclear Medicine Diagnostics Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Prostate Cancer Nuclear Medicine Diagnostics Company Profiles

      • 11.1 Telix Pharmaceuticals Ltd

        • 11.1.1 Telix Pharmaceuticals Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Telix Pharmaceuticals Ltd Prostate Cancer Nuclear Medicine Diagnostics Product Profiles, Application and Specification

        • 11.1.3 Telix Pharmaceuticals Ltd Prostate Cancer Nuclear Medicine Diagnostics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Alliance Medical

        • 11.2.1 Alliance Medical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Alliance Medical Prostate Cancer Nuclear Medicine Diagnostics Product Profiles, Application and Specification

        • 11.2.3 Alliance Medical Prostate Cancer Nuclear Medicine Diagnostics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 NCM-USA LLC

        • 11.3.1 NCM-USA LLC Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 NCM-USA LLC Prostate Cancer Nuclear Medicine Diagnostics Product Profiles, Application and Specification

        • 11.3.3 NCM-USA LLC Prostate Cancer Nuclear Medicine Diagnostics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Jubilant Pharma Limited

        • 11.4.1 Jubilant Pharma Limited Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Jubilant Pharma Limited Prostate Cancer Nuclear Medicine Diagnostics Product Profiles, Application and Specification

        • 11.4.3 Jubilant Pharma Limited Prostate Cancer Nuclear Medicine Diagnostics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 PETNET Solutions Inc

        • 11.5.1 PETNET Solutions Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 PETNET Solutions Inc Prostate Cancer Nuclear Medicine Diagnostics Product Profiles, Application and Specification

        • 11.5.3 PETNET Solutions Inc Prostate Cancer Nuclear Medicine Diagnostics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Novartis AG

        • 11.6.1 Novartis AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Novartis AG Prostate Cancer Nuclear Medicine Diagnostics Product Profiles, Application and Specification

        • 11.6.3 Novartis AG Prostate Cancer Nuclear Medicine Diagnostics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Cardinal Health

        • 11.7.1 Cardinal Health Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Cardinal Health Prostate Cancer Nuclear Medicine Diagnostics Product Profiles, Application and Specification

        • 11.7.3 Cardinal Health Prostate Cancer Nuclear Medicine Diagnostics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 Lantheus Medical Imagining, Inc

        • 11.8.1 Lantheus Medical Imagining, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 Lantheus Medical Imagining, Inc Prostate Cancer Nuclear Medicine Diagnostics Product Profiles, Application and Specification

        • 11.8.3 Lantheus Medical Imagining, Inc Prostate Cancer Nuclear Medicine Diagnostics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 Cancer Genetics, Inc

        • 11.9.1 Cancer Genetics, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 Cancer Genetics, Inc Prostate Cancer Nuclear Medicine Diagnostics Product Profiles, Application and Specification

        • 11.9.3 Cancer Genetics, Inc Prostate Cancer Nuclear Medicine Diagnostics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.10 Curium Pharma

        • 11.10.1 Curium Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.10.2 Curium Pharma Prostate Cancer Nuclear Medicine Diagnostics Product Profiles, Application and Specification

        • 11.10.3 Curium Pharma Prostate Cancer Nuclear Medicine Diagnostics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.11 Blue Earth Diagnostics

        • 11.11.1 Blue Earth Diagnostics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.11.2 Blue Earth Diagnostics Prostate Cancer Nuclear Medicine Diagnostics Product Profiles, Application and Specification

        • 11.11.3 Blue Earth Diagnostics Prostate Cancer Nuclear Medicine Diagnostics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.12 ImaginAb

        • 11.12.1 ImaginAb Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.12.2 ImaginAb Prostate Cancer Nuclear Medicine Diagnostics Product Profiles, Application and Specification

        • 11.12.3 ImaginAb Prostate Cancer Nuclear Medicine Diagnostics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.13 American Pride

        • 11.13.1 American Pride Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.13.2 American Pride Prostate Cancer Nuclear Medicine Diagnostics Product Profiles, Application and Specification

        • 11.13.3 American Pride Prostate Cancer Nuclear Medicine Diagnostics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.14 Theragnostics Ltd

        • 11.14.1 Theragnostics Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.14.2 Theragnostics Ltd Prostate Cancer Nuclear Medicine Diagnostics Product Profiles, Application and Specification

        • 11.14.3 Theragnostics Ltd Prostate Cancer Nuclear Medicine Diagnostics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.15 Sun Nuclear Corporation

        • 11.15.1 Sun Nuclear Corporation Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.15.2 Sun Nuclear Corporation Prostate Cancer Nuclear Medicine Diagnostics Product Profiles, Application and Specification

        • 11.15.3 Sun Nuclear Corporation Prostate Cancer Nuclear Medicine Diagnostics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Prostate Cancer Nuclear Medicine Diagnostics Industry Investment Prospect and Risk Assessment

    • 12.1 Prostate Cancer Nuclear Medicine Diagnostics Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Prostate Cancer Nuclear Medicine Diagnostics Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Prostate Cancer Nuclear Medicine Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure China Prostate Cancer Nuclear Medicine Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure Global Prostate Cancer Nuclear Medicine Diagnostics Production Value and Growth Rate (2017-2028)

    • Figure China Prostate Cancer Nuclear Medicine Diagnostics Production Value and Growth Rate (2017-2028)

    • Figure Global Prostate Cancer Nuclear Medicine Diagnostics Market Size and Growth Rate of Single Photon Emission Computed Tomography (2017-2028)

    • Figure Global Prostate Cancer Nuclear Medicine Diagnostics Market Size and Growth Rate of Positron Emission Tomography (2017-2028)

    • Figure Global Prostate Cancer Nuclear Medicine Diagnostics Market Size and Growth Rate of Hospitals (2017-2028)

    • Figure Global Prostate Cancer Nuclear Medicine Diagnostics Market Size and Growth Rate of Clinics (2017-2028)

    • Figure Global Prostate Cancer Nuclear Medicine Diagnostics Market Size and Growth Rate of Others (2017-2028)

    • Figure North America Prostate Cancer Nuclear Medicine Diagnostics Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Prostate Cancer Nuclear Medicine Diagnostics Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Prostate Cancer Nuclear Medicine Diagnostics Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Prostate Cancer Nuclear Medicine Diagnostics Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Prostate Cancer Nuclear Medicine Diagnostics Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Prostate Cancer Nuclear Medicine Diagnostics Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Prostate Cancer Nuclear Medicine Diagnostics Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Prostate Cancer Nuclear Medicine Diagnostics Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Prostate Cancer Nuclear Medicine Diagnostics Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Prostate Cancer Nuclear Medicine Diagnostics Market Share, by Manufacturer in 2021

    • Figure Global and China Prostate Cancer Nuclear Medicine Diagnostics Market Share, by Manufacturer in 2022

    • Table Global Prostate Cancer Nuclear Medicine Diagnostics Sales Volume, by Type (2017-2028)

    • Table Global Prostate Cancer Nuclear Medicine Diagnostics Sales Volume Share, by Type (2017-2028)

    • Figure Global Prostate Cancer Nuclear Medicine Diagnostics Sales Volume Share, by Type (2017-2028)

    • Table Global Prostate Cancer Nuclear Medicine Diagnostics Sales Value, by Type (2017-2028)

    • Table Global Prostate Cancer Nuclear Medicine Diagnostics Sales Value Share, by Type (2017-2028)

    • Figure Global Prostate Cancer Nuclear Medicine Diagnostics Price Trend, by Type (2017-2028)

    • Table China Prostate Cancer Nuclear Medicine Diagnostics Sales Volume, by Type (2017-2028)

    • Table China Prostate Cancer Nuclear Medicine Diagnostics Sales Volume Share, by Type (2017-2028)

    • Figure China Prostate Cancer Nuclear Medicine Diagnostics Sales Volume Share, by Type (2017-2028)

    • Table China Prostate Cancer Nuclear Medicine Diagnostics Sales Value, by Type (2017-2028)

    • Table China Prostate Cancer Nuclear Medicine Diagnostics Sales Value Share, by Type (2017-2028)

    • Figure China Prostate Cancer Nuclear Medicine Diagnostics Price Trend, by Type (2017-2028)

    • Table Global Prostate Cancer Nuclear Medicine Diagnostics Sales Volume, by Application (2017-2028)

    • Table Global Prostate Cancer Nuclear Medicine Diagnostics Sales Volume Share, by Application (2017-2028)

    • Figure Global Prostate Cancer Nuclear Medicine Diagnostics Sales Volume Share, by Application (2017-2028)

    • Table Global Prostate Cancer Nuclear Medicine Diagnostics Sales Value, by Application (2017-2028)

    • Table Global Prostate Cancer Nuclear Medicine Diagnostics Sales Value Share, by Application (2017-2028)

    • Figure Global Prostate Cancer Nuclear Medicine Diagnostics Sales Value Share, by Application (2017-2028)

    • Table China Prostate Cancer Nuclear Medicine Diagnostics Sales Volume, by Application (2017-2028)

    • Table China Prostate Cancer Nuclear Medicine Diagnostics Sales Volume Share, by Application (2017-2028)

    • Figure China Prostate Cancer Nuclear Medicine Diagnostics Sales Volume Share, by Application (2017-2028)

    • Table China Prostate Cancer Nuclear Medicine Diagnostics Sales Value, by Application (2017-2028)

    • Table China Prostate Cancer Nuclear Medicine Diagnostics Sales Value Share, by Application (2017-2028)

    • Figure China Prostate Cancer Nuclear Medicine Diagnostics Sales Value Share, by Application (2017-2028)

    • Figure China Prostate Cancer Nuclear Medicine Diagnostics Production, Import, Consumption and Export (2017-2022)

    • Figure North America Prostate Cancer Nuclear Medicine Diagnostics Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Prostate Cancer Nuclear Medicine Diagnostics Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Prostate Cancer Nuclear Medicine Diagnostics Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Prostate Cancer Nuclear Medicine Diagnostics Production, Import, Consumption and Export (2017-2022)

    • Table North America Prostate Cancer Nuclear Medicine Diagnostics Sales Volume, by Type (2017-2028)

    • Table North America Prostate Cancer Nuclear Medicine Diagnostics Sales Volume Share, by Type (2017-2028)

    • Figure North America Prostate Cancer Nuclear Medicine Diagnostics Sales Volume Share, by Type (2017-2028)

    • Table North America Prostate Cancer Nuclear Medicine Diagnostics Sales Volume, by Application (2017-2028)

    • Table North America Prostate Cancer Nuclear Medicine Diagnostics Sales Volume Share, by Application (2017-2028)

    • Figure North America Prostate Cancer Nuclear Medicine Diagnostics Sales Volume Share, by Application (2017-2028)

    • Figure United States Prostate Cancer Nuclear Medicine Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure United States Prostate Cancer Nuclear Medicine Diagnostics Sales Value and Growth Rate (2017-2028)

    • Figure Canada Prostate Cancer Nuclear Medicine Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Prostate Cancer Nuclear Medicine Diagnostics Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Prostate Cancer Nuclear Medicine Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Prostate Cancer Nuclear Medicine Diagnostics Sales Value and Growth Rate (2017-2028)

    • Table Europe Prostate Cancer Nuclear Medicine Diagnostics Sales Volume, by Type (2017-2028)

    • Table Europe Prostate Cancer Nuclear Medicine Diagnostics Sales Volume Share, by Type (2017-2028)

    • Figure Europe Prostate Cancer Nuclear Medicine Diagnostics Sales Volume Share, by Type (2017-2028)

    • Table Europe Prostate Cancer Nuclear Medicine Diagnostics Sales Volume, by Application (2017-2028)

    • Table Europe Prostate Cancer Nuclear Medicine Diagnostics Sales Volume Share, by Application (2017-2028)

    • Figure Europe Prostate Cancer Nuclear Medicine Diagnostics Sales Volume Share, by Application (2017-2028)

    • Figure Germany Prostate Cancer Nuclear Medicine Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Prostate Cancer Nuclear Medicine Diagnostics Sales Value and Growth Rate (2017-2028)

    • Figure UK Prostate Cancer Nuclear Medicine Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure UK Prostate Cancer Nuclear Medicine Diagnostics Sales Value and Growth Rate (2017-2028)

    • Figure France Prostate Cancer Nuclear Medicine Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure France Prostate Cancer Nuclear Medicine Diagnostics Sales Value and Growth Rate (2017-2028)

    • Figure Italy Prostate Cancer Nuclear Medicine Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Prostate Cancer Nuclear Medicine Diagnostics Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Prostate Cancer Nuclear Medicine Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Prostate Cancer Nuclear Medicine Diagnostics Sales Value and Growth Rate (2017-2028)

    • Figure Spain Prostate Cancer Nuclear Medicine Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Prostate Cancer Nuclear Medicine Diagnostics Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Prostate Cancer Nuclear Medicine Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Prostate Cancer Nuclear Medicine Diagnostics Sales Value and Growth Rate (2017-2028)

    • Figure Poland Prostate Cancer Nuclear Medicine Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Prostate Cancer Nuclear Medicine Diagnostics Sales Value and Growth Rate (2017-2028)

    • Figure Russia Prostate Cancer Nuclear Medicine Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Prostate Cancer Nuclear Medicine Diagnostics Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Prostate Cancer Nuclear Medicine Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Prostate Cancer Nuclear Medicine Diagnostics Sales Value and Growth Rate (2017-2028)

    • Table APAC Prostate Cancer Nuclear Medicine Diagnostics Sales Volume, by Type (2017-2028)

    • Table APAC Prostate Cancer Nuclear Medicine Diagnostics Sales Volume Share, by Type (2017-2028)

    • Figure APAC Prostate Cancer Nuclear Medicine Diagnostics Sales Volume Share, by Type (2017-2028)

    • Table APAC Prostate Cancer Nuclear Medicine Diagnostics Sales Volume, by Application (2017-2028)

    • Table APAC Prostate Cancer Nuclear Medicine Diagnostics Sales Volume Share, by Application (2017-2028)

    • Figure APAC Prostate Cancer Nuclear Medicine Diagnostics Sales Volume Share, by Application (2017-2028)

    • Figure China Prostate Cancer Nuclear Medicine Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure China Prostate Cancer Nuclear Medicine Diagnostics Sales Value and Growth Rate (2017-2028)

    • Figure Japan Prostate Cancer Nuclear Medicine Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Prostate Cancer Nuclear Medicine Diagnostics Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Prostate Cancer Nuclear Medicine Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Prostate Cancer Nuclear Medicine Diagnostics Sales Value and Growth Rate (2017-2028)

    • Figure India Prostate Cancer Nuclear Medicine Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure India Prostate Cancer Nuclear Medicine Diagnostics Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Prostate Cancer Nuclear Medicine Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Prostate Cancer Nuclear Medicine Diagnostics Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Prostate Cancer Nuclear Medicine Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Prostate Cancer Nuclear Medicine Diagnostics Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Prostate Cancer Nuclear Medicine Diagnostics Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Prostate Cancer Nuclear Medicine Diagnostics Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Prostate Cancer Nuclear Medicine Diagnostics Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Prostate Cancer Nuclear Medicine Diagnostics Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Prostate Cancer Nuclear Medicine Diagnostics Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Prostate Cancer Nuclear Medicine Diagnostics Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Prostate Cancer Nuclear Medicine Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Prostate Cancer Nuclear Medicine Diagnostics Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Prostate Cancer Nuclear Medicine Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Prostate Cancer Nuclear Medicine Diagnostics Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Prostate Cancer Nuclear Medicine Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Prostate Cancer Nuclear Medicine Diagnostics Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Prostate Cancer Nuclear Medicine Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Prostate Cancer Nuclear Medicine Diagnostics Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Prostate Cancer Nuclear Medicine Diagnostics Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Prostate Cancer Nuclear Medicine Diagnostics Sales Value and Growth Rate (2017-2028)

    • Table Telix Pharmaceuticals Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Telix Pharmaceuticals Ltd Product Profiles, Application and Specification

    • Table Telix Pharmaceuticals Ltd Prostate Cancer Nuclear Medicine Diagnostics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Alliance Medical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Alliance Medical Product Profiles, Application and Specification

    • Table Alliance Medical Prostate Cancer Nuclear Medicine Diagnostics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table NCM-USA LLC Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table NCM-USA LLC Product Profiles, Application and Specification

    • Table NCM-USA LLC Prostate Cancer Nuclear Medicine Diagnostics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Jubilant Pharma Limited Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Jubilant Pharma Limited Product Profiles, Application and Specification

    • Table Jubilant Pharma Limited Prostate Cancer Nuclear Medicine Diagnostics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table PETNET Solutions Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table PETNET Solutions Inc Product Profiles, Application and Specification

    • Table PETNET Solutions Inc Prostate Cancer Nuclear Medicine Diagnostics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Novartis AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Novartis AG Product Profiles, Application and Specification

    • Table Novartis AG Prostate Cancer Nuclear Medicine Diagnostics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Cardinal Health Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Cardinal Health Product Profiles, Application and Specification

    • Table Cardinal Health Prostate Cancer Nuclear Medicine Diagnostics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Lantheus Medical Imagining, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Lantheus Medical Imagining, Inc Product Profiles, Application and Specification

    • Table Lantheus Medical Imagining, Inc Prostate Cancer Nuclear Medicine Diagnostics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Cancer Genetics, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Cancer Genetics, Inc Product Profiles, Application and Specification

    • Table Cancer Genetics, Inc Prostate Cancer Nuclear Medicine Diagnostics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Curium Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Curium Pharma Product Profiles, Application and Specification

    • Table Curium Pharma Prostate Cancer Nuclear Medicine Diagnostics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Blue Earth Diagnostics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Blue Earth Diagnostics Product Profiles, Application and Specification

    • Table Blue Earth Diagnostics Prostate Cancer Nuclear Medicine Diagnostics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table ImaginAb Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table ImaginAb Product Profiles, Application and Specification

    • Table ImaginAb Prostate Cancer Nuclear Medicine Diagnostics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table American Pride Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table American Pride Product Profiles, Application and Specification

    • Table American Pride Prostate Cancer Nuclear Medicine Diagnostics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Theragnostics Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Theragnostics Ltd Product Profiles, Application and Specification

    • Table Theragnostics Ltd Prostate Cancer Nuclear Medicine Diagnostics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Sun Nuclear Corporation Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Sun Nuclear Corporation Product Profiles, Application and Specification

    • Table Sun Nuclear Corporation Prostate Cancer Nuclear Medicine Diagnostics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US